Study period 1/1/2017 to 7/1/2025 Study population: inclusion Patients with A GLP-1 prescription for at least 90 days At least five pounds of weight loss while on the GLP-1 A weight reading between 30 days prior through 3 days after starting the GLP-1 A weight reading within 30 days of stopping the GLP-1 At least one weight reading 1 to 24 months following end of the GLP-1 Study population: exclusion Thyroid conditions (ever): ICD-10-CM E03*or E05* Eating disorders (ever): ICD-10-CM F50* Pregnancy within a year before GLP-1 start through GLP-1 stop Censoring Other weight loss medication or restart of GLP-1 Amputation Bariatric surgery Pregnancy that started in period after GLP-1 was stopped Outcomes Percent of weight change relative to initial weight loss after end of GLP-1 treatment GLP-1 A medication with a simple generic of semaglutide, liraglutide, or tirzepatide
Alopecia associated with semaglutide and tirzepatide: a pharmacovigilance study (FAERS)
Potential risks of compounded semaglutide: Compounded semaglutide may have the following risks depending on the pharmacy you buy from
At Klinic, our board-certified providers specialize in semaglutide weight loss treatments, ensuring you get the best care possible
Symptoms of acid reflux can vary widely but often include: Heartburn, a burning sensation in your chest Regurgitation of food or sour liquid Difficulty swallowing A sensation of a lump in your throat Several factors can exacerbate acid reflux, such as obesity, dietary choices, smoking, and certain medications
We suggest weekly semaglutide injections to help your levels stay the same over time
